RAPS Regulatory Intelligence Conference

June 6 – 7 | Hilton Baltimore BWI Airport |

Baltimore, MD

About The Conference

The AgencyIQ Team will be attending RAPS Regulatory Intelligence Conference, at Hilton Baltimore BWI Airport, in Baltimore, MD. This conference is part of RAPS new Conference Series, designed to explore key regulatory affairs topics in a collaborative and engaging environment.

See Us There

AgencyIQ’s Executive Director, Regulatory Policy And Intelligence, Alexander Gaffney, and Research Director, Laura DiAngelo, will be attending the conference and speaking at multiple sessions.

Alexander Gaffney

Executive Director, Regulatory Policy and Intelligence

Laura DiAngelo

Research Director

AgencyIQ Sessions

Opening Plenary: Preparing for the Next Round of User Fee Negotiations

Thursday, June 6, 2024, 9:00am – 10:15am EDT

Alexander Gaffney, MS, RAC

In this engaging and lively opening plenary session, hear from some of the regulatory policy professionals who have sat at the user fee negotiating table before and learn more about how user fee programs come into existence – and what we should look forward to next.

Staying Ahead of the Curve: The Nuts and Bolts of Monitoring and Disseminating External Regulatory Agency News and Publications in Drug and Device Companies

Thursday, June 6, 2024, 11:55pm – 12:55pm EDT

Alexander Gaffney, MS, RAC

This session discusses the practical aspects of monitoring and disseminating regulatory updates within drug and device companies, providing insights on effective monitoring strategies, communication practices, and the importance of an internal communication strategy, illustrated through case studies.

Medical Device Hot Topics and Troubleshooting Q&A

Thursday, June 6, 2024, 4:00pm – 5:00pm EDT

Laura DiAngelo, MPH

At this session, regulatory affairs professionals will be able to ask questions and seek feedback from panelists in an interactive forum, building dialogue on how to approach challenges or topic areas in a systematic way.

Navigating the Complex Landscape: Understanding the Impact of New Guidance and Laws on Drug Development Companies

Friday, June 7, 2024, 9:00am – 10:00am EDT

Alexander Gaffney, MS, RAC

This session offers a deep dive into the impact of new regulatory changes on the drug development industry, providing insights into integrating these changes into operations, risk management, clinical trial design, design changes and market access, along with case studies from organizations that have successfully navigated these shifts.

Navigating the Complex Landscape: Understanding the Impact of New Guidance and Laws on Medical Device Companies

Friday, June 7, 2024, 9:00am – 10:00am EDT

Laura DiAngelo, MPH

This session offers a deep dive into the impact of new regulatory changes on the medical device industry, providing insights into integrating these changes into operations, risk management, clinical trial design, design changes and market access, along with case studies from organizations that have successfully navigated these shifts.

Insights to your Inbox

Sign up for our free newsletter, FDA Today, to stay up to date on the latest FDA developments that impact the life sciences industry and receive samples of the extensive premium research and analysis our regulatory experts provide exclusively to AgencyIQ subscribers.

About AgencyIQ by POLITICO

The modern regulatory environment is complex and ever changing. AgencyIQ, a division of POLITICO, is a strategic partner and extension of clients’ teams by offering regulatory professionals reliable access to analysis and insights, real-time data, and non-partisan journalism. Our vision is to enable businesses to deeply understand, seamlessly track and productively engage regulators to accelerate action and improve outcomes.

FOLLOW NOW